Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on schizophrenia.
Location not clearly listedThis study is completed in Germany. It focuses on Anxiety.
In GermanyThis study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
Multiple locations, including Little RockThis study is completed in Germany. It is testing atomoxetine for ADHD.
Multiple locations, including CologneThis study is completed in Germany. It is testing atomoxetine for ADHD.
In CologneThis study is enrolling by invitation in the United States. It is testing azetukalner for depression.
Multiple locations, including Little RockThis study is enrolling by invitation in the United States. It is testing azetukalner for depression.
Multiple locations, including PhoenixThis study is completed in the United States. It is testing lamictal for OCD.
In MinneapolisThis study is completed in the United States, in Bulgaria, in Czechia, .... It is testing lumateperone for depression.
Multiple locations, including PhoenixThis study is completed in the United States. It is testing naltrexone for ADHD.
In BostonThis study is completed in the United States. It is testing NRP104 for ADHD.
Multiple locations, including Little Rock
This study is completed in Italy. It focuses on ADHD.
In ItalyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.